B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 1997-06-01
著者
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Tobinai Kensei
東海大学 医学部
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
MATSUNO Yoshihiro
Pathology Division, National Cancer Center Hospital
-
Takeuchi T
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takeuchi Takahiro
愛知県立がんセンター病院
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Takeyama Kunihiko
東海大学 医学部
-
Takeyama Kunihiko
Department Of Hematology/oncology National Cancer Center Hospital
-
Nakata M
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Nakata Masanobu
東海大学 医学部血液・腫瘍内科
-
Nakata Masanobu
Department Of Plant Protection Faculty Of Agriculture Kobe University
-
Terauchi Takashi
国立がんセンター中央病院 血液内科
-
Yokozawa Toshiya
豊橋市民病院 血液・腫瘍内科
-
Yokozawa T
Nagoya Univ. Graduate Schol Of Medicine Nagoya Jpn
-
Yokozawa Toshiya
Department Of Hematology Nagoya University Graduate School Of Medicine
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Takeuchi Takahiro
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takahashi Toshitada
愛知県がんセンター研究所 腫瘍免疫学
-
TOBINAI Kensei
Department of Pharmacotherapy, National Cancer Institute
-
TAKENAKA Takeaki
Department of Medical Oncology, National Cancer Center Hospital
-
KOBAYASHI Yukio
Department of Medical Oncology, National Cancer Center Hospital
-
Tobinai Kensei
Hematology Division National Cancer Center Hospital
-
Takemoto Yoshinobu
Department Of Pathology Okayama University Medical School
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Nakata Masanobu
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Yokozawa Toshiya
Hematology Division National Cancer Center Hospital
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Takenaka T
National Cancer Center Hospital Tokyo Jpn
-
Terauchi Takashi
Diagnostic Radiology Divisions National Cancer Center Hospital
-
Yoshino Tadashi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Matsuno Yoshihiro
Pathology Division National Cancer Center Hospital
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Yokozawa Toshiya
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Narabayashi Masaru
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Takeyama Kunihiko
Department Of Hematology Harasanshin General Hospital
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Tobinai Kensei
Department Of Molecular Medicine And Hematology Molecular Medicine Unit Atomic Bomb Disease Institut
-
Kobayashi Yukio
Department Of Hematology Nephrology And Rheumatology Akita University Graduate School Of Medicine
-
Kobayashi Yukio
Department Of Chemistry Faculity Of Science Tokai University
-
Kobayashi Takayuki
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Nakata Masanobu
Department Of Hematology Sapporo Hokuyu Hospital
-
TOBINAI Kensei
Department of Hematology, National Cancer Center Hospital
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma